{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.248G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "248"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "83"
          },
          "Description in input context": "c.248G>A (p.G83D)"
        }
      ]
    },
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.1699C>Y",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "C",
            "alt": "Y",
            "position": "1699"
          },
          "Protein Change": {
            "ref": "C",
            "alt": "R",
            "position": "570"
          },
          "Description in input context": "c.1699C>Y (p.C570R)"
        }
      ]
    },
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.2385R",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "R",
            "alt": "T",
            "position": "2385"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "K",
            "position": "794"
          },
          "Description in input context": "c.2385R (p.R794K)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "LRRK2-related parkinsonism",
    "MONDO": "MONDO:0019837"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vivo models (transgenic flies)",
      "Material used": {
        "Material Source": "Mouse (transgenic)",
        "Material Name": "LRRK2 alleles",
        "Description": "Transgenic mice were generated with wild-type or mutant LRRK2 alleles."
      },
      "Readout type": "Behavioral and toxicological",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.248G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural change in the protein affecting its function",
          "Result Description": "DA neuron functionality was disrupted, and locomotor activity decreased on day 7."
        },
        {
          "Variant": "NM_001126112.3:c.1699C>Y",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural change in the protein affecting its function",
          "Result Description": "DA neuron functionality was disrupted, and locomotor activity decreased on day 7."
        },
        {
          "Variant": "NM_001126112.3:c.2385R",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural change in the protein affecting its function",
          "Result Description": "DA neuron functionality was disrupted, and locomotor activity decreased on day 7."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Three biological replicates were performed for each cluster of dopaminergic neurons."
      },
      "Technical replicates": {
        "Technical replicates": "Each sample was assayed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 alleles were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Mouse models lacking the LRRK2 gene were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Two positive controls for each variant were included.",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "One negative control for each variant was included.",
        "Counts": "1"
      },
      "Statistical analysis method": "ANOVA followed by post-hoc testing for pairwise comparisons",
      "Threshold for normal readout": {
        "Threshold for normal readout": "DA neuron functionality remained intact and locomotor activity was normal in the wild-type model on day 7.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "DA neuron functionality was significantly impaired, and locomotor activity decreased by at least 30% on day 7.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes (approved methods for studying LRRK2-related neurodegenerative diseases)"
      }
    }
  ]
}